As you are aware, we are facing uncertain economic times which have contributed to a record increase in client enrollment. The lingering economic downturn has forced us to take cost containment measures to ensure currently-enrolled clients continue to receive their medications without disruption in medical treatment.

Beginning June 1, 2010 the Florida AIDS Drug Assistance Program (ADAP) will institute a waiting list. The purpose of the waiting list is to ensure availability of HIV treatment medications for all ADAP clients currently enrolled. Also, effective August 1, 2010 the ADAP formulary will be reduced to Antiretroviral (ARV) and Opportunistic Infection (OI) medications.

In our efforts to provide a time-sensitive, solution-based response, we have assembled this Comprehensive Cost Containment Guidance (Zip file, 7MB and opens in new window) to ensure ADAP staff, case managers, and providers have the necessary tools to assist clients.

Please note: Pregnant women, pediatric or adolescent individuals who meet ADAP enrollment criteria and are not eligible for other programs are exempt from being placed on the waiting list and will be immediately enrolled for services. Providers can request a medical review for patient(s) who have an extreme medical condition.  Reviews and approval will be done by the HIV/AIDS Bureau's medical staff.

We recognize that maintaining a sustainable drug assistance program is a critical need in our state. The Bureau of HIV/AIDS is currently working with Federal and State government officials as well as statewide community partners to secure additional resources. Every effort in reducing the impact of any cost containment measures is carefully considered and evaluated to ensure the most effective and proactive response during these challenging times.

Sincerely,

 Bureau of HIV/AIDS,
AIDS Drug Assistance Program

Other important Documents

*All PDF files are under 5MB and open in new windows